IL6 and neoplasm: The decrease in CD40 expression levels can down-regulate VEGF, IL-6, and other factors, reducing the risk of CSCC by promoting endothelial cell apoptosis, inhibiting the growth of vascular endothelial cells, and inhibiting tumor angiogenesis.